Umeclidinium
Also known as: Incruse, Incruse Ellipta, Umeclidinium Ellipta.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Package | Class |
|---|---|---|---|---|
| 62.5 MCG | Inhaler | $7.45 / unit | $223.43 / 30 EA box | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Box prices are per full package where the size is known.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $60,090,091 gross for Umeclidinium across 159,962 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$375,858,548 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS